Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Josef Pasulka"'
Autor:
Lenka Kasikova, Jana Rakova, Michal Hensler, Tereza Lanickova, Jana Tomankova, Josef Pasulka, Jana Drozenova, Katerina Mojzisova, Anna Fialova, Sarka Vosahlikova, Jan Laco, Ales Ryska, Pavel Dundr, Roman Kocian, Tomas Brtnicky, Petr Skapa, Linda Capkova, Marek Kovar, Jan Prochazka, Ivan Praznovec, Vladimir Koblizek, Alice Taskova, Hisashi Tanaka, Robert Lischke, Fernando Casas Mendez, Jiri Vachtenheim, Viola Heinzelmann-Schwarz, Francis Jacob, Iain A. McNeish, Michal J. Halaska, Lukas Rob, David Cibula, Sandra Orsulic, Lorenzo Galluzzi, Radek Spisek, Jitka Fucikova
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract Intratumoral tertiary lymphoid structures (TLSs) have been associated with improved outcome in various cohorts of patients with cancer, reflecting their contribution to the development of tumor-targeting immunity. Here, we demonstrate that h
Externí odkaz:
https://doaj.org/article/51ecc26da57243349eb37f9d6e8d150d
Autor:
Peter Holicek, Iva Truxova, Jana Rakova, Cyril Salek, Michal Hensler, Marek Kovar, Milan Reinis, Romana Mikyskova, Josef Pasulka, Sarka Vosahlikova, Hana Remesova, Iva Valentova, Daniel Lysak, Monika Holubova, Petr Kaspar, Jan Prochazka, Lenka Kasikova, Radek Spisek, Lorenzo Galluzzi, Jitka Fucikova
Publikováno v:
Cell Death and Disease, Vol 14, Iss 3, Pp 1-12 (2023)
Abstract While type I interferon (IFN) is best known for its key role against viral infection, accumulating preclinical and clinical data indicate that robust type I IFN production in the tumor microenvironment promotes cancer immunosurveillance and
Externí odkaz:
https://doaj.org/article/f8edc52886a84c80a88c6cee32d03c15
Autor:
Jan Petrzilek, Josef Pasulka, Radek Malik, Filip Horvat, Shubhangini Kataruka, Helena Fulka, Petr Svoboda
Publikováno v:
BMC Biology, Vol 20, Iss 1, Pp 1-14 (2022)
Abstract Background Genes, principal units of genetic information, vary in complexity and evolutionary history. Less-complex genes (e.g., long non-coding RNA (lncRNA) expressing genes) readily emerge de novo from non-genic sequences and have high evo
Externí odkaz:
https://doaj.org/article/2779d6741ced470cb55cdae8383a2d1c
Autor:
Michal Hensler, Jana Rakova, Lenka Kasikova, Tereza Lanickova, Josef Pasulka, Peter Holicek, Marek Hraska, Tereza Hrnciarova, Pavla Kadlecova, Andreu Schoenenberger, Klara Sochorova, Daniela Rozkova, Ludek Sojka, Jana Drozenova, Jan Laco, Rudolf Horvath, Michal Podrazil, Guo Hongyan, Tomas Brtnicky, Michal J. Halaska, Lukas Rob, Ales Ryska, An Coosemans, Ignace Vergote, Abhishek D. Garg, David Cibula, Jirina Bartunkova, Radek Spisek, Jitka Fucikova
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Dendritic cells (DCs) have received considerable attention as potential targets for the development of novel cancer immunotherapies. However, the clinical efficacy of DC-based vaccines remains suboptimal, largely reflecting local and systemic immunos
Externí odkaz:
https://doaj.org/article/8aa6cc35d16f49fbb0529e5fcefe2e0f
Autor:
Jana Rakova, Iva Truxova, Peter Holicek, Cyril Salek, Michal Hensler, Lenka Kasikova, Josef Pasulka, Monika Holubova, Marek Kovar, Daniel Lysak, Justin P. Kline, Zdenek Racil, Lorenzo Galluzzi, Radek Spisek, Jitka Fucikova
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Accumulating evidence indicates that immune checkpoint inhibitors (ICIs) can restore CD8+ cytotoxic T lymphocyte (CTL) functions in preclinical models of acute myeloid leukemia (AML). However, ICIs targeting programmed cell death 1 (PDCD1, best known
Externí odkaz:
https://doaj.org/article/7aa2896ab527498bac5610f866169e29
Autor:
Eliska Taborska, Josef Pasulka, Radek Malik, Filip Horvat, Irena Jenickova, Zoe Jelić Matošević, Petr Svoboda
Publikováno v:
PLoS Genetics, Vol 15, Iss 12, p e1008261 (2019)
Germline genome defense evolves to recognize and suppress retrotransposons. One of defensive mechanisms is the PIWI-associated RNA (piRNA) pathway, which employs small RNAs for sequence-specific repression. The loss of the piRNA pathway in mice cause
Externí odkaz:
https://doaj.org/article/007a744a174d4a50a8c308a9ca77841f
Autor:
Jitka Fucikova, Michal Hensler, Lenka Kasikova, Tereza Lanickova, Josef Pasulka, Jana Rakova, Jana Drozenova, Tessa Fredriksen, Marek Hraska, Tereza Hrnciarova, Klara Sochorova, Daniela Rozkova, Ludek Sojka, Pavel Dundr, Jan Laco, Tomas Brtnicky, Ivan Praznovec, Michael J. Halaska, Lukas Rob, Ales Ryska, An Coosemans, Ignace Vergote, David Cibula, Jirina Bartunkova, Jérôme Galon, Lorenzo Galluzzi, Radek Spisek
Publikováno v:
Clinical Cancer Research. 28:3053-3065
Purpose: The successful implementation of immune checkpoint inhibitors (ICI) in the clinical management of various solid tumors has raised considerable expectations for patients with epithelial ovarian carcinoma (EOC). However, EOC is poorly responsi
Autor:
Radek Spisek, Lorenzo Galluzzi, Jérôme Galon, Jirina Bartunkova, David Cibula, Ignace Vergote, An Coosemans, Ales Ryska, Lukas Rob, Michael J. Halaska, Ivan Praznovec, Tomas Brtnicky, Jan Laco, Pavel Dundr, Ludek Sojka, Daniela Rozkova, Klara Sochorova, Tereza Hrnciarova, Marek Hraska, Tessa Fredriksen, Jana Drozenova, Jana Rakova, Josef Pasulka, Tereza Lanickova, Lenka Kasikova, Michal Hensler, Jitka Fucikova
Purpose:The successful implementation of immune checkpoint inhibitors (ICI) in the clinical management of various solid tumors has raised considerable expectations for patients with epithelial ovarian carcinoma (EOC). However, EOC is poorly responsiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2edf464bb0e75cf494ef22f2a9c051d7
https://doi.org/10.1158/1078-0432.c.6532535.v1
https://doi.org/10.1158/1078-0432.c.6532535.v1
Autor:
Radek Spisek, Lorenzo Galluzzi, Jérôme Galon, Jirina Bartunkova, David Cibula, Ignace Vergote, An Coosemans, Ales Ryska, Lukas Rob, Michael J. Halaska, Ivan Praznovec, Tomas Brtnicky, Jan Laco, Pavel Dundr, Ludek Sojka, Daniela Rozkova, Klara Sochorova, Tereza Hrnciarova, Marek Hraska, Tessa Fredriksen, Jana Drozenova, Jana Rakova, Josef Pasulka, Tereza Lanickova, Lenka Kasikova, Michal Hensler, Jitka Fucikova
Supplementary Figure from An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e506ae0712ba6bc0b2b40bb8ae64b8e
https://doi.org/10.1158/1078-0432.22487537.v1
https://doi.org/10.1158/1078-0432.22487537.v1
Autor:
Radek Spisek, Lorenzo Galluzzi, Jérôme Galon, Jirina Bartunkova, David Cibula, Ignace Vergote, An Coosemans, Ales Ryska, Lukas Rob, Michael J. Halaska, Ivan Praznovec, Tomas Brtnicky, Jan Laco, Pavel Dundr, Ludek Sojka, Daniela Rozkova, Klara Sochorova, Tereza Hrnciarova, Marek Hraska, Tessa Fredriksen, Jana Drozenova, Jana Rakova, Josef Pasulka, Tereza Lanickova, Lenka Kasikova, Michal Hensler, Jitka Fucikova
Supplementary Data from An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b4b7a2a67f69a0b15d6f449d601cab1
https://doi.org/10.1158/1078-0432.22487543
https://doi.org/10.1158/1078-0432.22487543